BIOCRYST PHARMACEUTICALS INC
Develops oral small-molecule drugs for rare diseases like hereditary angioedema.
BCRX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US09058V1035
- LEI:
- Country:
- United States of America
- Address:
- 4505 EMPEROR BOULEVARD, 27703 DURHAM
- Website:
- https://www.biocryst.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BioCryst Pharmaceuticals Inc. is a commercial-stage biotechnology company focused on the discovery, development, and commercialization of novel medicines for rare diseases. The company specializes in creating oral small-molecule and protein therapeutics for patients with significant unmet medical needs, with a primary focus on hereditary angioedema (HAE) and other complement-mediated conditions. Founded in 1986, BioCryst utilizes a structure-guided drug design approach that combines biology, chemistry, and advanced technologies to develop first-in-class or best-in-class treatments. The company's mission is to improve patients' lives by advancing novel therapeutics globally.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BIOCRYST PHARMACEUTICALS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BIOCRYST PHARMACEUTICALS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BIOCRYST PHARMACEUTICALS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
